Together with our collaborative
partner, Coldstream Labs, GoodwinBiotechnology has the experience, expertise, and capability to develop and
manufacture highly potent CADCs from proof of concept through to non-clinical
and clinical use, late stage as well as commercial manufacturing.
Goodwin Biotechnology is a full-service,
customer-focused and integrated contract services provider with a pioneering
focus on the development and manufacturing of Cytotoxic Antibody Drug
Conjugates (CADCs) from cell line development or exploratory proof-of-concept
through process development, scale up, and cGMP manufacturing.
